{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:34:06Z","timestamp":1785810846474,"version":"3.56.0"},"reference-count":156,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Sj\u00f6gren\u2019s disease (SjD) is a chronic autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and progressive secretory dysfunction. Although the major molecular abnormalities in SjD, including prominent type I interferon activation and abnormal B-cell responses, are now better defined, these findings have not consistently translated into effective disease-modifying therapy. A persistent gap therefore remains between biological target engagement and clinical benefit. This review argues that this gap may partly reflect a mismatch between current pathological models of SjD and the way clinical trials are designed. Conventional frameworks often treat SjD as a relatively homogeneous inflammatory disease and rely heavily on systemic disease-activity measures. Such approaches may underrepresent the spatiotemporal evolution of the salivary gland microenvironment and the heterogeneity of treatment responses across tissue states. Drawing on recent evidence, including single-cell RNA sequencing, spatial transcriptomics, and longitudinal histological studies, we propose a tissue-centered interpretive framework for SjD. This framework highlights three partially overlapping dimensions: epithelial activation states linked to nucleic-acid-sensing and interferon-related programs; lymphoid organization and B-cell-supportive niches associated with IFN-BAFF and Tfh\/Tph-related activity; and later structural remodeling associated with fibrosis, impaired regeneration, and reduced functional reversibility. These dimensions are used here as interpretive constructs rather than as validated clinical staging categories. On this basis, precision medicine in SjD may need to move beyond a uniform anti-inflammatory strategy toward mechanism-based stratification anchored in tissue state and disease stage. Biomarkers such as salivary gland ultrasonography, TLS-related features, and microenvironment-linked molecular readouts may help refine patient stratification, endpoint selection, and clinical trial design, although these applications still require prospective validation.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1863280","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:06:32Z","timestamp":1784095592000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Spatiotemporal orchestration of the salivary gland immune microenvironment in Sj\u00f6gren\u2019s disease: a multidimensional framework of epithelial licensing, lymphoid neogenesis, and stromal remodeling"],"prefix":"10.3389","volume":"17","author":[{"given":"Shouze","family":"Ren","sequence":"first","affiliation":[{"name":"Heilongjiang University of Chinese Medicine","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Li","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Chinese Medicine","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Niu","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Chinese Medicine","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing Mentougou District Hospital of Traditional Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Chinese Medicine","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiadong","family":"Yang","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Chinese Medicine","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Liang","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Chinese Medicine","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3821","article-title":"Primary sjogren syndrome","volume":"344","author":"Ramos-Casals","year":"2012","journal-title":"Bmj"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-01057-6","article-title":"Epidemiology of sj\u00f6gren syndrome","volume":"20","author":"Beydon","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.13341","article-title":"Hospitalizations due to systemic connective tissue diseases: secular trends and regional disparities in Sweden, 1998-2016","volume":"21","author":"Kiadaliri","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2017.1324909","article-title":"Systematic review and meta-analysis of the epidemiology of polyautoimmunity in sj\u00f6gren's syndrome (secondary sj\u00f6gren's syndrome) focusing on autoimmune rheumatic diseases","volume":"47","author":"Alani","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary sj\u00f6gren's syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200207000-00003","article-title":"Primary sj\u00f6gren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients","volume":"81","author":"Garc\u00eda-Carrasco","year":"2002","journal-title":"Med (Baltimore)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.144782","article-title":"Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of Malignant lymphoma in primary sj\u00f6gren's syndrome","volume":"70","author":"Theander","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary sj\u00f6gren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116189","article-title":"Predicting the outcome of sjogren's syndrome-associated non-hodgkin's lymphoma patients","volume":"10","author":"Papageorgiou","year":"2015","journal-title":"PloS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102316","article-title":"Predictive markers of lymphomagenesis in sj\u00f6gren's syndrome: from clinical data to molecular stratification","volume":"104","author":"Kapsogeorgou","year":"2019","journal-title":"J Autoimmun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090734","article-title":"Estimating indirect costs in primary sj\u00f6gren's syndrome","volume":"37","author":"Bowman","year":"2010","journal-title":"J Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003591","article-title":"Estimated prevalence, incidence and healthcare costs of sj\u00f6gren's syndrome in France: a national claims-based study","volume":"10","author":"Seror","year":"2024","journal-title":"RMD Open"},{"key":"B13","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41467-023-36369-4","article-title":"Author correction: genome-wide association study identifies sj\u00f6gren's risk loci with functional implications in immune and glandular cells","volume":"14","author":"Khatri","year":"2023","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa367","article-title":"Genetic and clinical basis for two distinct subtypes of primary sj\u00f6gren's syndrome","volume":"60","author":"Thorlacius","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2792","article-title":"Variants at multiple loci implicated in both innate and adaptive immune responses are associated with sj\u00f6gren's syndrome","volume":"45","author":"Lessard","year":"2013","journal-title":"Nat Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020272","article-title":"Primary sjogren syndrome: focus on innate immune cells and inflammation","volume":"8","author":"Rizzo","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.980400","article-title":"Nucleic acid-sensing toll-like receptors: important players in sj\u00f6gren's syndrome","volume":"13","author":"Alexopoulou","year":"2022","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2023.2209720","article-title":"Emerging treatment for sj\u00f6gren's disease: a review of recent phase II and III trials","volume":"28","author":"Fox","year":"2023","journal-title":"Expert Opin Emerg Drugs"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(20)30038-2","article-title":"Rationale for CD40 pathway blockade in autoimmune rheumatic disorders","volume":"2","author":"Pucino","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.7682","article-title":"Effects of hydroxychloroquine on symptomatic improvement in primary sj\u00f6gren syndrome: the JOQUER randomized clinical trial","volume":"312","author":"Gottenberg","year":"2014","journal-title":"Jama"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/art.40093","article-title":"Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary sj\u00f6gren's syndrome","volume":"69","author":"Bowman","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez242","article-title":"Hydroxychloroquine treatment downregulates systemic interferon activation in primary sj\u00f6gren's syndrome in the JOQUER randomized trial","volume":"59","author":"Bodewes","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/biom11070953","article-title":"Instruments for outcome evaluation of specific domains in primary sj\u00f6gren's syndrome","volume":"11","author":"Del Papa","year":"2021","journal-title":"Biomolecules"},{"key":"B24","article-title":"Physical fatigue characterises patient experience of primary sj\u00f6gren's syndrome","volume":"35","author":"Arends","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1759720x17746319","article-title":"Management of primary sj\u00f6gren's syndrome: recent developments and new classification criteria","volume":"10","author":"Del Papa","year":"2018","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54686-0","article-title":"Molecular and spatial analysis of tertiary lymphoid structures in sjogren's syndrome","volume":"16","author":"Nayar","year":"2025","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1038\/s41467-025-63935-9","article-title":"Comparative single-cell and spatial profiling of anti-SSA-positive and anti-centromere-positive sj\u00f6gren's disease reveals common and distinct immune activation and fibroblast-mediated inflammation","volume":"16","author":"Inamo","year":"2025","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2311983120","article-title":"Normal and sjogren's syndrome models of the murine lacrimal gland studied at single-cell resolution","volume":"120","author":"Rattner","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab466","article-title":"New developments in sjogren's syndrome","volume":"60","author":"Thalayasingam","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00605-2","article-title":"Epithelial-immune cell interplay in primary sj\u00f6gren syndrome salivary gland pathogenesis","volume":"17","author":"Verstappen","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.clim.2017.03.007","article-title":"Insight into pathogenesis of sj\u00f6gren's syndrome: dissection on autoimmune infiltrates and epithelial cells","volume":"182","author":"Goules","year":"2017","journal-title":"Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1405126","article-title":"Advances in cellular and molecular pathways of salivary gland damage in sj\u00f6gren's syndrome","volume":"15","author":"Qi","year":"2024","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1566377","article-title":"Proteins linked to type II interferon response in sj\u00f6gren's disease: novel indicators for disease monitoring and predicting treatment response to leflunomide and hydroxychloroquine combination therapy","volume":"16","author":"Wong","year":"2025","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","article-title":"Type I and II interferon signatures in sjogren's syndrome pathogenesis: contributions in distinct clinical phenotypes and sjogren's related lymphomagenesis","volume":"63","author":"Nezos","year":"2015","journal-title":"J Autoimmun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.10.006","article-title":"Type I interferons in sj\u00f6gren's syndrome","volume":"12","author":"Yao","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/art.39204","article-title":"Molecular subsetting of interferon pathways in sj\u00f6gren's syndrome","volume":"67","author":"Hall","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/biom11020251","article-title":"The role of interferons in the pathogenesis of sj\u00f6gren's syndrome and future therapeutic perspectives","volume":"11","author":"Del Papa","year":"2021","journal-title":"Biomolecules"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/art.42844","article-title":"Amplified type I interferon response in sj\u00f6gren's disease via ectopic toll-like receptor 7 expression in salivary gland epithelial cells induced by lysosome-associated membrane protein 3","volume":"76","author":"Nakamura","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.705079","article-title":"Serum, but not saliva, CXCL13 levels associate with infiltrating CXCL13+ cells in the minor salivary gland lesions and other histologic parameters in patients with sj\u00f6gren's syndrome","volume":"12","author":"Chatzis","year":"2021","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key360","article-title":"Innate immunity and interferons in the pathogenesis of sj\u00f6gren's syndrome","volume":"60","author":"Bodewes","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.967304","article-title":"Composition and regulation of the immune microenvironment of salivary gland in sj\u00f6gren's syndrome","volume":"13","author":"Tan","year":"2022","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.823659","article-title":"The role of virus infections in sj\u00f6gren's syndrome","volume":"13","author":"Maslinska","year":"2022","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02314","article-title":"Regulatory NLRs control the RLR-mediated type I interferon and inflammatory responses in human dendritic cells","volume":"9","author":"Fekete","year":"2018","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41419-025-07717-7","article-title":"Application of imaging mass cytometry for spatially profiling the microenvironment of salivary glands in primary sj\u00f6gren's syndrome","volume":"16","author":"Wu","year":"2025","journal-title":"Cell Death Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1289492","article-title":"Functional significance of DNA methylation: epigenetic insights into sj\u00f6gren's syndrome","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102867","article-title":"Dysfunctional mitochondria as critical players in the inflammation of autoimmune diseases: potential role in sj\u00f6gren's syndrome","volume":"20","author":"Barrera","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.83801","article-title":"Lactate-induced mtDNA accumulation activates cGAS-STING signaling and the inflammatory response in sj\u00f6gren's syndrome","volume":"20","author":"Xu","year":"2023","journal-title":"Int J Med Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00142","article-title":"The interferon-signature of sj\u00f6gren's syndrome: how unique biomarkers can identify underlying inflammatory and immunopathological mechanisms of specific diseases","volume":"4","author":"Nguyen","year":"2013","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1649046","article-title":"STING pathways and sj\u00f6gren's syndrome: exploration from mechanism to treatment","volume":"16","author":"Ka","year":"2025","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/art.39795","article-title":"Expression of long interspersed nuclear element 1 retroelements and induction of type I interferon in patients with systemic autoimmune disease","volume":"68","author":"Mavragani","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00071","article-title":"The contribution of epigenetics in Sj\u00f6gren's syndrome","volume":"5","author":"Konsta","year":"2014","journal-title":"Front Genet"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103673","article-title":"Sjogren's syndrome: Everything you always wanted to know about genetic and epigenetic factors","volume":"23","author":"Perricone","year":"2024","journal-title":"Autoimmun Rev"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1421436","article-title":"Immune and non-immune mediators in the fibrosis pathogenesis of salivary gland in Sj\u00f6gren's syndrome","volume":"15","author":"Ma","year":"2024","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1097\/bor.0b013e32836200d2","article-title":"Autoimmunity and infection in Sj\u00f6gren's syndrome","volume":"25","author":"Igoe","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-007-8007-4","article-title":"The role of epithelial cells in the pathogenesis of Sj\u00f6gren's syndrome","volume":"32","author":"Manoussakis","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1443455","article-title":"The role of cytokines from salivary gland epithelial cells in the immunopathology of Sj\u00f6gren's syndrome","volume":"15","author":"Dong","year":"2024","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0113036","article-title":"CXCL13 is elevated in Sj\u00f6gren's syndrome in mice and humans and is implicated in disease pathogenesis","volume":"94","author":"Kramer","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01952","article-title":"Tertiary lymphoid structures: Autoimmunity goes local","volume":"9","author":"Pipi","year":"2018","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxaf078","article-title":"The 'target tissues' as orchestrators of autoimmune responses: the paradigm of Sj\u00f6gren's syndrome","volume":"220","author":"Filika","year":"2026","journal-title":"Clin Exp Immunol"},{"key":"B60","article-title":"Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sj\u00f6gren's syndrome","volume":"29","author":"Tsunawaki","year":"2002","journal-title":"J Rheumatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.7326\/M13-1085","article-title":"Treatment of primary Sj\u00f6gren syndrome with rituximab: a randomized trial","volume":"160","author":"Devauchelle-Pensec","year":"2014","journal-title":"Ann Intern Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fdmed.2025.1590516","article-title":"Multiparameter flow cytometry enables immune profiling and IFN pathway analysis in human minor salivary glands","volume":"6","author":"Yamada","year":"2025","journal-title":"Front Dent Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s509220","article-title":"Updating on the dual role of salivary gland epithelial cell (SGEC) in Sj\u00f6gren's disease","volume":"18","author":"Zhu","year":"2025","journal-title":"J Inflammation Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.850998","article-title":"Role of the CXCL13\/CXCR5 axis in autoimmune diseases","volume":"13","author":"Pan","year":"2022","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clim.2016.01.015","article-title":"Early BAFF receptor blockade mitigates murine Sj\u00f6gren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction","volume":"164","author":"Sharma","year":"2016","journal-title":"Clin Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-222054","article-title":"Development and preliminary validation of the Sj\u00f6gren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sj\u00f6gren's syndrome","volume":"81","author":"Seror","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2023.05.027","article-title":"Interferon-\u03b3 induces salivary gland epithelial cell ferroptosis in Sjogren's syndrome via JAK\/STAT1-mediated inhibition of system Xc()","volume":"205","author":"Cao","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127417","article-title":"Pathogenesis and treatment of Sjogren's syndrome: Review and update","volume":"14","author":"Zhan","year":"2023","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224842","article-title":"Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sj\u00f6gren's disease","volume":"83","author":"Gupta","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12987","article-title":"Stromal cells in tertiary lymphoid structures: Architects of autoimmunity","volume":"302","author":"Asam","year":"2021","journal-title":"Immunol Rev"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212268","article-title":"Effect of rituximab on a salivary gland ultrasound score in primary Sj\u00f6gren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy","volume":"77","author":"Fisher","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B72","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13075-020-02249-1","article-title":"Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sj\u00f6gren's syndrome","volume":"22","author":"Yamada","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev420","article-title":"Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sj\u00f6gren's syndrome","volume":"55","author":"Thompson","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-020-00637-0","article-title":"Expression of BAFF and BAFF receptors in primary Sj\u00f6gren's syndrome patients with ectopic germinal center-like structures","volume":"20","author":"Carrillo-Ballesteros","year":"2020","journal-title":"Clin Exp Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241311179","article-title":"Outline of salivary gland pathogenesis of Sj\u00f6gren's syndrome and current therapeutic approaches","volume":"24","author":"Yura","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203991","article-title":"Efficacy and safety of belimumab in primary Sj\u00f6gren's syndrome: results of the BELISS open-label phase II study","volume":"74","author":"Mariette","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102712","article-title":"Mapping the B-cell axis in Sj\u00f6gren's disease: repertoire, microenvironment, and potential routes to precision treatment","volume":"98","author":"Chatzis","year":"2026","journal-title":"Curr Opin Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(19)30135-3","article-title":"Assessment of the anti-CD40 antibody iscalimab in patients with primary Sj\u00f6gren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study","volume":"2","author":"Fisher","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152385","article-title":"Identification of outcome domains in primary Sj\u00f6gren's disease: A scoping review by the OMERACT Sj\u00f6gren disease working group","volume":"65","author":"Nguyen","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(24)00039-0","article-title":"Precision medicine in Sj\u00f6gren's disease","volume":"6","author":"Gandolfo","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.684999","article-title":"The multiple roles of B cells in the pathogenesis of Sj\u00f6gren's syndrome","volume":"12","author":"Du","year":"2021","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2012.09.013","article-title":"Novel autoantibodies in Sjogren's syndrome","volume":"145","author":"Shen","year":"2012","journal-title":"Clin Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1172\/jci200214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sj\u00f6gren's syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J Clin Invest"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes180","article-title":"BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands","volume":"52","author":"Quartuccio","year":"2013","journal-title":"Rheumatol (Oxford)"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062567","article-title":"BAFF and MyD88 signals promote a lupuslike disease independent of T cells","volume":"204","author":"Groom","year":"2007","journal-title":"J Exp Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.05.006","article-title":"B-cell tolerance breakdown in Sj\u00f6gren's syndrome: focus on BAFF","volume":"9","author":"Varin","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00509","article-title":"Non-canonical NF-\u03baB signaling initiated by BAFF influences B cell biology at multiple junctures","volume":"4","author":"Gardam","year":"2014","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1523392","article-title":"Exploring the role of APRIL in autoimmunity: implications for therapeutic targeting in systemic lupus erythematosus, rheumatoid arthritis, and Sj\u00f6gren's syndrome","volume":"16","author":"Poznyak","year":"2025","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00634-x","article-title":"Current and future therapies for primary Sj\u00f6gren syndrome","volume":"17","author":"Seror","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102439","article-title":"Gene expression profiling of epithelium-associated FcRL4(+) B cells in primary Sj\u00f6gren's syndrome reveals a pathogenic signature","volume":"109","author":"Verstappen","year":"2020","journal-title":"J Autoimmun"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1665086","article-title":"B cell subpopulations and their role in the pathogenesis of primary Sj\u00f6gren's syndrome: insights from single-cell RNA sequencing","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.163030","article-title":"A randomized, phase II study of sequential belimumab and rituximab in primary Sj\u00f6gren's syndrome","volume":"7","author":"Mariette","year":"2022","journal-title":"JCI Insight"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev005","article-title":"Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome","volume":"54","author":"Pontarini","year":"2015","journal-title":"Rheumatol (Oxford)"},{"key":"B94","first-page":"199","article-title":"Double anti-B cell and anti-BAFF targeting for the treatment of primary Sj\u00f6gren's syndrome","author":"Gandolfo","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004112","article-title":"Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sj\u00f6gren's disease","volume":"10","author":"Felten","year":"2024","journal-title":"RMD Open"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/i8iszc","article-title":"Pathogenesis of Sj\u00f6gren's disease: one year in review 2024","volume":"42","author":"Baldini","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1345381","article-title":"Chemokines and lymphocyte homing in Sj\u00f6gren's syndrome","volume":"15","author":"Liao","year":"2024","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez052","article-title":"Lymphomas complicating primary Sj\u00f6gren's syndrome: from autoimmunity to lymphoma","volume":"60","author":"Nocturne","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201216","article-title":"Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL\/6 mice","volume":"189","author":"Bombardieri","year":"2012","journal-title":"J Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/odi.13276","article-title":"Bcl6 for identification of germinal centres in salivary gland biopsies in primary Sj\u00f6gren's syndrome","volume":"26","author":"Nakshbandi","year":"2020","journal-title":"Oral Dis"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30662","article-title":"Characterisation of follicular dendritic cells in labial salivary glands of patients with primary Sj\u00f6gren syndrome: comparison with tonsillar lymphoid follicles","volume":"56","author":"Aziz","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217646","article-title":"Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sj\u00f6gren's syndrome with ectopic germinal centres and MALT lymphoma","volume":"79","author":"Pontarini","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.900349","article-title":"Tph cells expanded in primary Sj\u00f6gren's syndrome","volume":"9","author":"Chen","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/art.21062","article-title":"Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sj\u00f6gren's syndrome","volume":"52","author":"Barone","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06210-2","article-title":"Elevated CXCL13 in primary Sj\u00f6gren's syndrome and its correlation with disease activity: a systematic review and meta-analysis","volume":"41","author":"Zhu","year":"2022","journal-title":"Clin Rheumatol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.08.007","article-title":"Lymphomagenesis in Sj\u00f6gren's syndrome: Predictive biomarkers towards precision medicine","volume":"18","author":"Goules","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(24)00183-8","article-title":"Identification and evolution of predictors of Sj\u00f6gren's disease-associated mucosa-associated lymphoid tissue lymphoma development over time: a case-control study","volume":"6","author":"Goules","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v91.6.1864.1864_1864_1872","article-title":"Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sj\u00f6gren's syndrome) begin as nonmalignant antigen-selected expansions","volume":"91","author":"Bahler","year":"1998","journal-title":"Blood"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab939","article-title":"Clinical picture, outcome and predictive factors of lymphoma in primary Sj\u00f6gren's syndrome: results from a harmonized dataset (1981-2021)","volume":"61","author":"Chatzis","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.666545","article-title":"Autoimmune B cell repertoire in a mouse model of Sj\u00f6gren's syndrome","volume":"12","author":"S\u00e1ez Moya","year":"2021","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001442","article-title":"Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sj\u00f6gren syndrome","volume":"7","author":"Dupr\u00e9","year":"2021","journal-title":"RMD Open"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.05.014","article-title":"B cells in Sj\u00f6gren's syndrome: from pathophysiology to diagnosis and treatment","volume":"39","author":"Cornec","year":"2012","journal-title":"J Autoimmun"},{"key":"B113","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.beha.2016.09.002","article-title":"MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism","volume":"30","author":"Du","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09576.x","article-title":"Primary cutaneous B-cell lymphoma is associated with somatically hypermutated immunoglobulin variable genes and frequent use of VH1-69 and VH4-59 segments","volume":"162","author":"Perez","year":"2010","journal-title":"Br J Dermatol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/art.41263","article-title":"Salivary gland mucosa-associated lymphoid tissue-type lymphoma from Sj\u00f6gren's syndrome patients in the majority express rheumatoid factors affinity-selected for IgG","volume":"72","author":"Bende","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.5mr1020-057rr","article-title":"Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sj\u00f6gren's syndrome","volume":"109","author":"Chen","year":"2021","journal-title":"J Leukoc Biol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-503383","article-title":"Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome","volume":"122","author":"Nocturne","year":"2013","journal-title":"Blood"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2019.12.018","article-title":"Case report of API2-MALT1 fusion-positive MALT lymphoma arising from bilateral submandibular glands with no evidence of autoimmune syndromes","volume":"130","author":"Ishibashi","year":"2020","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/art.39002","article-title":"Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sj\u00f6gren's syndrome","volume":"67","author":"Bende","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102717","article-title":"Markers predicting lymphoma development in Sj\u00f6gren disease: current status and future perspectives","volume":"99","author":"Panagiotopoulos","year":"2026","journal-title":"Curr Opin Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3390\/biom16010072","article-title":"A narrative review of salivary gland extracellular matrix and Sj\u00f6gren's syndrome: research status and future prospects","volume":"16","author":"Su","year":"2026","journal-title":"Biomolecules"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094973","article-title":"Exploring salivary epithelial dysfunction in Sj\u00f6gren's disease","volume":"25","author":"Noll","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B123","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s40001-024-01967-5","article-title":"Primary Sj\u00f6gren's syndrome: new perspectives on salivary gland epithelial cells","volume":"29","author":"Hou","year":"2024","journal-title":"Eur J Med Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107943","article-title":"Single-cell transcriptome profiling reveals immune and stromal cell heterogeneity in primary Sj\u00f6gren's syndrome","volume":"26","author":"Xiang","year":"2023","journal-title":"iScience"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jobcr.2024.03.005","article-title":"Cell type-specific transforming growth factor-\u03b2 (TGF-\u03b2) signaling in the regulation of salivary gland fibrosis and regeneration","volume":"14","author":"Mu\u00f1oz Forti","year":"2024","journal-title":"J Oral Biol Craniofac Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"11154","DOI":"10.1038\/s41598-021-90569-w","article-title":"Gene expression alterations in salivary gland epithelia of Sj\u00f6gren's syndrome patients are associated with clinical and histopathological manifestations","volume":"11","author":"Dela Cruz","year":"2021","journal-title":"Sci Rep"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/life13101991","article-title":"EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI) and other patient-reported outcomes in the assessment of glandular dysfunction in primary Sj\u00f6gren's syndrome","volume":"13","author":"Ture","year":"2023","journal-title":"Life (Basel)"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)02644-1","article-title":"Primary Sj\u00f6gren's syndrome: new beginning for evidence-based trials","volume":"399","author":"Saraux","year":"2022","journal-title":"Lancet"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265057","article-title":"Salivary gland ultrasound is associated with the presence of autoantibodies in patients with Sj\u00f6gren's syndrome: a Danish single-centre study","volume":"17","author":"Schmidt","year":"2022","journal-title":"PloS One"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.707104","article-title":"Biological therapy in primary Sj\u00f6gren's syndrome: effect on salivary gland function and inflammation","volume":"8","author":"Chowdhury","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2019.01.025","article-title":"Assessment of major salivary gland size in primary Sj\u00f6gren's syndrome: comparison between clinical examination and ultrasonography","volume":"86","author":"Marteau","year":"2019","journal-title":"Joint Bone Spine"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226498","article-title":"Disease activity and damage in patients with primary Sjogren's syndrome: prognostic value of salivary gland ultrasonography","volume":"14","author":"Milic","year":"2019","journal-title":"PloS One"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100803","article-title":"Analysis of gene expression and TCR\/B cell receptor profiling of immune cells in primary Sj\u00f6gren's syndrome by single-cell sequencing","volume":"209","author":"Hou","year":"2022","journal-title":"J Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063203","article-title":"SMADS-mediate molecular mechanisms in Sj\u00f6gren's syndrome","volume":"22","author":"Sisto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239138","article-title":"TGF-\u03b2 pathway in salivary gland fibrosis","volume":"21","author":"Zhang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.699722","article-title":"Sclerosing sialadenitis is associated with salivary gland hypofunction and a unique gene expression profile in Sj\u00f6gren's syndrome","volume":"12","author":"Yin","year":"2021","journal-title":"Front Immunol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41584-023-00932-6","article-title":"Genetics and epigenetics of primary Sj\u00f6gren syndrome: implications for future therapies","volume":"19","author":"Thorlacius","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208659","article-title":"Genome-wide DNA methylation analysis in multiple tissues in primary Sj\u00f6gren's syndrome reveals regulatory effects at interferon-induced genes","volume":"75","author":"Imgenberg-Kreuz","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B139","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/sji.12121","article-title":"Upregulation of membrane-bound CD40L on CD4+ T cells in women with primary Sj\u00f6gren's syndrome","volume":"79","author":"Belkhir","year":"2014","journal-title":"Scand J Immunol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa012","article-title":"Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sj\u00f6gren's syndrome","volume":"59","author":"Wang","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B141","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13075-019-1961-4","article-title":"Proteomic and histopathological characterisation of sicca subjects and primary Sj\u00f6gren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers","volume":"21","author":"Aqrawi","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B142","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12979-025-00541-9","article-title":"Salivary gland cell senescence in Sj\u00f6gren's syndrome: current research and novel therapeutic directions","volume":"22","author":"Tang","year":"2025","journal-title":"Immun Ageing"},{"key":"B143","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jobcr.2023.08.009","article-title":"Extracellular matrix turnover in salivary gland disorders and regenerative therapies: obstacles and opportunities","volume":"13","author":"Marinkovic","year":"2023","journal-title":"J Oral Biol Craniofac Res"},{"key":"B144","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13619-025-00221-5","article-title":"Salivary gland stem\/progenitor cells: advancing from basic science to clinical applications","volume":"14","author":"Langthasa","year":"2025","journal-title":"Cell Regener"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119817","article-title":"The impact of alternate-day fasting on the salivary gland stem cell compartments in non-obese diabetic mice with newly established Sj\u00f6gren's syndrome","volume":"1871","author":"Li","year":"2024","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-024-01135-3","article-title":"Update on the pathophysiology and treatment of primary Sj\u00f6gren syndrome","volume":"20","author":"Baldini","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2026.102737","article-title":"Minor salivary gland biopsy in Sjogren's disease: a diagnostic and prognostic tool toward precision medicine","volume":"99","author":"Chatzis","year":"2026","journal-title":"Curr Opin Immunol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.701581","article-title":"Inflammatory stratification in primary Sj\u00f6gren's syndrome reveals novel immune cell alterations in patients' minor salivary glands","volume":"12","author":"Bharaj","year":"2021","journal-title":"Front Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key330","article-title":"Genetics and epigenetics in primary Sj\u00f6gren's syndrome","volume":"60","author":"Imgenberg-Kreuz","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.05.004","article-title":"Primary Sj\u00f6gren's disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sj\u00f6gren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)","volume":"84","author":"Bowman","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2024-1012","article-title":"A systematic review of clinical trial designs and outcome measures in Sj\u00f6gren disease randomized controlled trials","volume":"52","author":"Beydon","year":"2025","journal-title":"J Rheumatol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-025-07369-0","article-title":"Clinical value of salivary gland ultrasonography in evaluating secretory function, disease activity, and lymphoma risk factors in primary Sj\u00f6gren's syndrome","volume":"44","author":"Yang","year":"2025","journal-title":"Clin Rheumatol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"305","DOI":"10.21203\/rs.3.rs-664060\/v1","article-title":"Salivary gland ultrasonography in primary Sj\u00f6gren's syndrome from diagnosis to clinical stratification: a multicentre study","volume":"23","author":"Zhang","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15041478","article-title":"Activity and damage indices for Sj\u00f6gren's disease","volume":"15","author":"Portier","year":"2026","journal-title":"J Clin Med"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102707","article-title":"Salivary gland organoids and the future of modeling autoimmune epithelitis in Sj\u00f6gren's disease","volume":"98","author":"Yang","year":"2026","journal-title":"Curr Opin Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1002\/art.41127","article-title":"Advances in disease mechanisms and translational technologies: Clinicopathologic significance of inflammasome activation in autoimmune diseases","volume":"72","author":"Kahlenberg","year":"2020","journal-title":"Arthritis Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1863280\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:06:34Z","timestamp":1784095594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1863280\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":156,"alternative-id":["10.3389\/fimmu.2026.1863280"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1863280","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1863280"}}